Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Contributor

Recovery & Performance Peptides Editorial Team

Editorial team for Recovery & Performance Peptides.

8515 published articles
By this contributor

Published articles

BPC-157 Side Effects: Overview

Key Takeaways BPC-157 is a synthetic peptide currently prohibited by the FDA for human use. Common side effects include nausea and dizziness, though data is limited. Serious side effects are rare but can include allergi…

Read article

BPC-157: Expert Answers to Common Questions

Key Takeaways BPC-157 is a synthetic peptide studied for its potential in tissue repair and recovery. It is not FDA-approved and falls under Category 2 (Prohibited) status. BPC-157 is administered via subcutaneous injec…

Read article

BPC-157 Dosing Protocols and Expectations

Key Takeaways BPC-157 is a synthetic peptide currently prohibited by the FDA for human use. Typical dosing protocols for research purposes range from 200 mcg to 500 mcg per day. Titration schedules are crucial for asses…

Read article